Thomas Stanislawski1, 6, Ralf-Holger Voss1, 6, Carina Lotz1, Elena Sadovnikova2, 7, Ralph A. Willemsen3, Jürgen Kuball1, Thomas Ruppert4, 8, Reinder L. H. Bolhuis3, Cornelius J. Melief5, Christoph Huber1, Hans J. Stauss2
& Matthias Theobald11
Department of Hematology and Oncology, Johannes Gutenberg University, D-55101 Mainz, Germany.
2
Department of Immunology, Hammersmith Hospital, Imperial College School of Medicine, London W12 0NN, UK.
3
Department of Clinical and Tumor Immunology, Daniel den Hoed Cancer Center, 3075 EA Rotterdam, The Netherlands.
4
Max von Pettenkofer Institute for Virology, Ludwig Maximilians University, D-80336 Munich, Germany.
5
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
6
These authors contributed equally to this work.
7
Present address: National Center for Hematology, 125167 Moscow, Russia.
8
Present address: Zentrum für Molekulare Biologie, Ruprecht-Karls University, D-69120 Heidelberg, Germany.
Correspondence should be addressed to Matthias Theobald m.theobald@3-med.klinik.uni-mainz.de
